Published by Michele Maatouk on 22nd January 2018
(ShareCast News) - Juno Therapeutics was set to surge at the open on Monday after agreeing for Celgene to buy the shares in the biopharmaceutical group it does not already own for around $9bn in cash.
URL: http://www.digitallook.com/dl/news/story/26960008/...